Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keisuke Shinohara

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Journal of Intensive Care|September 2, 2024
Impact of sympathetic hyperactivity induced by brain microglial activation on organ damage in sepsis with chronic kidney diseaseMasaaki Nishihara, Keisuke Shinohara, Shota Ikeda, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 23, 2025
Systolic blood pressure lower than 130 mmHg in heart failure with preserved ejection fraction: a systematic review and meta-analysis of clinical outcomesChisa Matsumoto, Michiaki Nagai, Keisuke Shinohara, et al.
The Analyst|December 24, 2025
Triggering isothermal exponential amplification of microRNA <i>via</i> liposome fusionMamiko Tsugane, Kosuke Kato, Keisuke Shinohara, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|May 15, 2012
Exercise training causes sympathoinhibition through antioxidant effect in the rostral ventrolateral medulla of hypertensive ratsTakuya Kishi, Yoshitaka Hirooka, Masato Katsuki, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|April 5, 2012
Combination therapy of olmesartan and azelnidipine inhibits sympathetic activity associated with reducing oxidative stress in the brain of hypertensive ratsKeisuke Shinohara, Yoshitaka Hirooka, Kiyohiro Ogawa, et al.
Frontiers in Digital Health|August 21, 2025
Correction: Online training program maintains motor functions and quality of life in patients with Parkinson's diseaseHiroshi Nakanishi, Ryoma Morigaki, Joji Fujikawa, et al.
Frontiers in Digital Health|November 28, 2024
Online training program maintains motor functions and quality of life in patients with Parkinson's diseaseHiroshi Nakanishi, Ryoma Morigaki, Joji Fujikawa, et al.
Case Reports in Neurology|March 4, 2026
Rare Abdominal Manifestations in a Patient with Parkinson's Disease after Deep Brain Stimulation of the Subthalamic Nucleus: A Case ReportHiroshi Koyama, Ryoma Morigaki, Kazuhisa Miyake, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|February 15, 2023
Nationwide Temporal Trends in Clinical Characteristics and Treatment of Dilated Cardiomyopathy From 2003 to 2013 in Japan - A Report From Clinical Personal RecordsYoshitomo Tsutsui, Shouji Matsushima, Nobuyuki Enzan, et al.
Journal of Hypertension|October 8, 2013
Moxonidine-induced central sympathoinhibition improves prognosis in rats with hypertensive heart failureNobuhiro Honda, Yoshitaka Hirooka, Koji Ito, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Journal of Intensive Care|September 2, 2024
Impact of sympathetic hyperactivity induced by brain microglial activation on organ damage in sepsis with chronic kidney diseaseMasaaki Nishihara, Keisuke Shinohara, Shota Ikeda, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 23, 2025
Systolic blood pressure lower than 130 mmHg in heart failure with preserved ejection fraction: a systematic review and meta-analysis of clinical outcomesChisa Matsumoto, Michiaki Nagai, Keisuke Shinohara, et al.
The Analyst|December 24, 2025
Triggering isothermal exponential amplification of microRNA <i>via</i> liposome fusionMamiko Tsugane, Kosuke Kato, Keisuke Shinohara, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|May 15, 2012
Exercise training causes sympathoinhibition through antioxidant effect in the rostral ventrolateral medulla of hypertensive ratsTakuya Kishi, Yoshitaka Hirooka, Masato Katsuki, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|April 5, 2012
Combination therapy of olmesartan and azelnidipine inhibits sympathetic activity associated with reducing oxidative stress in the brain of hypertensive ratsKeisuke Shinohara, Yoshitaka Hirooka, Kiyohiro Ogawa, et al.
Frontiers in Digital Health|August 21, 2025
Correction: Online training program maintains motor functions and quality of life in patients with Parkinson's diseaseHiroshi Nakanishi, Ryoma Morigaki, Joji Fujikawa, et al.
Frontiers in Digital Health|November 28, 2024
Online training program maintains motor functions and quality of life in patients with Parkinson's diseaseHiroshi Nakanishi, Ryoma Morigaki, Joji Fujikawa, et al.
Case Reports in Neurology|March 4, 2026
Rare Abdominal Manifestations in a Patient with Parkinson's Disease after Deep Brain Stimulation of the Subthalamic Nucleus: A Case ReportHiroshi Koyama, Ryoma Morigaki, Kazuhisa Miyake, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|February 15, 2023
Nationwide Temporal Trends in Clinical Characteristics and Treatment of Dilated Cardiomyopathy From 2003 to 2013 in Japan - A Report From Clinical Personal RecordsYoshitomo Tsutsui, Shouji Matsushima, Nobuyuki Enzan, et al.
Journal of Hypertension|October 8, 2013
Moxonidine-induced central sympathoinhibition improves prognosis in rats with hypertensive heart failureNobuhiro Honda, Yoshitaka Hirooka, Koji Ito, et al.
Pageof 8